Shinichi Koizumi
Direktor/Vorstandsmitglied bei TSUBOTA LABORATORY INCORPORATED
Aktive Positionen von Shinichi Koizumi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TSUBOTA LABORATORY INCORPORATED | Direktor/Vorstandsmitglied | 01.06.2020 | - |
Independent Dir/Board Member | 01.06.2020 | - | |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Direktor/Vorstandsmitglied | 01.01.2013 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 | - | |
Corporate Officer/Principal | 01.01.2013 | - |
Karriereverlauf von Shinichi Koizumi
Ehemalige bekannte Positionen von Shinichi Koizumi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RAQUALIA PHARMA INC. | Direktor/Vorstandsmitglied | 14.07.2011 | 01.08.2014 |
Technik-/Wissenschafts-/F&E-Leiter | 14.07.2011 | 29.11.2012 | |
Corporate Officer/Principal | - | - |
Ausbildung von Shinichi Koizumi
Tokyo Institute of Technology | Doctorate Degree |
Statistik
International
Japan | 5 |
Operativ
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
RAQUALIA PHARMA INC. | Health Technology |
TSUBOTA LABORATORY INCORPORATED | Commercial Services |
Private Unternehmen | 1 |
---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Börse
- Insiders
- Shinichi Koizumi
- Erfahrung